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Is it time to loosen the restrictions 
on athletes with cardiac disorders 
competing in sport?
Rui Providência,1 Carina Teixeira,2 Oliver Segal,1 Augustus Ullstein,3 
Kim T Mueser,2 Pier Lambiase1
Sudden cardiac death (SCD) in young 
athletes is a rare and dramatic event. Initial 
consensus guidelines from 2005 recom-
mend restriction from competitive sports 
for all athletes with hereditary cardiomy-
opathies and channelopathies, with very 
minor exceptions.1
The fIeld has changed: new daTa 
supporT a new approach
After decades of a conservative sports 
cardiology approach, recent findings 
call these universal restrictions into 
question. First, data on the use of auto-
matic external defibrillators (AEDs) for 
witnessed sudden cardiac arrest (SCA) in 
sports have been reassuring.2 When SCA is 
properly recognised and an AED immedi-
ately available, survival from SCA during 
sport is largely possible.
Second, two reports, one focusing 
on long QT syndrome in athletes,3 and 
another on catecholaminergic ventric-
ular tachycardia,4 have suggested that the 
risk of competition may be acceptable 
if athletes are well-informed and fully 
compliant with therapy. A recent task 
force of the American Heart Association 
and American College of Cardiology has 
suggested that competitive sports prac-
tice may be permissible in some athletes 
with channelopathies, assuming that 
appropriate precautionary measures are 
in place. Specifically, avoidance of exac-
erbating drugs, avoidance of dehydration, 
appropriate electrolyte replenishment 
(with drinks containing Mg2+ and K+) 
and establishment of an emergency action 
plan with staff trained in cardiopulmonary 
resuscitation and access to an AED.5
Third, in a recently analysis of 184 
consecutive deaths in patients with 
hypertrophic cardiomyopathy referred 
to a single cardiac pathology centre, the 
authors observed that 81% of deaths 
occurred at rest, unrelated to exertion.6 In 
most cases of sudden death on exertion, 
a diagnosis was missed during life. These 
data suggest that diagnosing these individ-
uals before a final ventricular arrhythmia 
occurs is of utmost importance, as it may 
allow the implementation of effective 
preventive measures, such as implantable 
cardioverter defibrillators (ICDs).
Fourth, our understanding of athletes 
with ICDs has progressed from data 
provided by the ICD Sports Safety Registry. 
In this multicentre, multinational registry 
no major adverse events (tachyarrhythmic 
death, externally resuscitated tachyar-
rhythmia during or after sports or severe 
injury resulting from arrhythmia-related 
syncope or shock during sports) were 
observed, suggesting that athletes can 
take part in sports without serious injury 
or failure of the ICD to terminate the 
arrhythmia.7
After following the trajectory of thou-
sands of disqualified athletes over the 
years, we now realise that we lacked 
knowledge about the natural history 
of these disease entities and that old 
recommendations1 were overcautious, as 
competitive sports might, after all, not 
cause a major cardiovascular event in all 
these individuals.
This understanding should prompt us to 
shift to a more balanced, but still cautious, 
approach when dealing with potential 
disqualification decisions in athletes with 
identified cardiac disorders.
TIme for aThleTe empowermenT
Over the past few decades, medicine 
in general has become more open to 
enabling the participation of patients in 
decisions about the diagnosis and treat-
ment of their conditions, a concept 
known as ‘empowerment’, which is 
being implemented more widely.8 A step 
forward with regard to cardiac disorders 
includes empowerment and shared deci-
sion-making, with placement of the athlete 
in a central role for planning their future.
Accordingly, we believe that it is the 
responsibility of the physician to inform 
athletes about the disease, natural history, 
treatment options, areas of uncertainty, 
and to assist them in making their deci-
sion based on their own values, and the 
underlying estimated risk of SCD. Can 
we deny these athletes the right to expose 
themselves to a small and uncertain risk 
that can be substantially reduced in most 
circumstances by AEDs, ICDs or medica-
tion, while we accept the risks of death or 
traumatic brain injury in motor sports and 
contact sports such as boxing/kick boxing, 
American football and rugby?
cardIac dIsorders and 
conTracTual Issues
A special situation occurs for team physi-
cians. Even though physicians employed 
by teams should still have the same 
empowering approach and obligations 
towards the athlete/patient, additional 
complexity and ethical issues arise when 
treating athletes finalising a financial 
contract. The team physician is obliged 
in his/her role to provide information to 
the team management about the athlete’s 
health status. Accordingly, management 
may be concerned about the risk of SCD 
and the effect on their club, the possibility 
of disease progression such that the athlete 
needs to abandon sports, or the potential 
impact on the transfer fee if trying to nego-
tiate with another club. If this occurs and 
the club aborts the signing of a contract, 
assuming the athlete is willing to compete, 
he/she will have to find a sports club who 
accepts the potential risks of the cardiac 
problem. It is ultimately up to the manage-
ment to decide whether or not they accept 
hiring of the athlete. However, it should 
be up to the athlete—not the physician—
whether they want to compete after being 
informed of the risk.
In conclusion, we believe this emerging 
evidence indicates that for many cardiac 
conditions the time has now come for 
sports cardiologists and team physicians 
to abandon a paternalistic approach and 
involve athletes in the decision-making 
process. After all, it is their lives and goals 
we are deciding, and to a certain point 
this can be considered a matter of free will 
and human rights. This should ideally be 
formalised in an informed consent process 
between the physician, athlete and sports 
team, outlining the known and unknown 
risks and recording that the athlete is 
making a fully informed decision to 
compete.
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